BBRR.F Stock Overview
Engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Blueberries Medical Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.013 |
| 52 Week High | CA$0.03 |
| 52 Week Low | CA$0.0054 |
| Beta | 1.51 |
| 11 Month Change | -14.77% |
| 3 Month Change | -14.65% |
| 1 Year Change | -2.68% |
| 33 Year Change | -86.80% |
| 5 Year Change | -94.75% |
| Change since IPO | -95.58% |
Recent News & Updates
Recent updates
Shareholder Returns
| BBRR.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 27.0% | -0.1% | 0.5% |
| 1Y | -2.7% | 19.2% | 20.5% |
Return vs Industry: BBRR.F underperformed the US Pharmaceuticals industry which returned 19.2% over the past year.
Return vs Market: BBRR.F underperformed the US Market which returned 20.5% over the past year.
Price Volatility
| BBRR.F volatility | |
|---|---|
| BBRR.F Average Weekly Movement | 33.2% |
| Pharmaceuticals Industry Average Movement | 9.8% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in US Market | 15.2% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: BBRR.F's share price has been volatile over the past 3 months.
Volatility Over Time: BBRR.F's weekly volatility (33%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Facundo Garreton | blueberriesmed.com |
Blueberries Medical Corp. engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia. It produces psychoactive and non-psychoactive cannabis by-products. The company is based in Vancouver, Canada.
Blueberries Medical Corp. Fundamentals Summary
| BBRR.F fundamental statistics | |
|---|---|
| Market cap | US$2.91m |
| Earnings (TTM) | -US$1.06m |
| Revenue (TTM) | US$218.56k |
26.7x
P/S Ratio-5.5x
P/E RatioIs BBRR.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BBRR.F income statement (TTM) | |
|---|---|
| Revenue | CA$299.27k |
| Cost of Revenue | CA$182.46k |
| Gross Profit | CA$116.81k |
| Other Expenses | CA$1.57m |
| Earnings | -CA$1.45m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0036 |
| Gross Margin | 39.03% |
| Net Profit Margin | -485.46% |
| Debt/Equity Ratio | 0% |
How did BBRR.F perform over the long term?
See historical performance and comparison